WhiteOak Capital Pharma and Healthcare Fund
Sectoral-PharmaVery HighOPEN-ENDED
- NAV as on 25 Sep 2026
- ₹17.02-0.12%1 day
- Return since launch
- 22.0%
- 52-week range
- ₹12.93 — ₹17.17
- AUM
- ₹902 Cr
WhiteOak Capital Pharma and Healthcare Fund is a Sectoral-Pharma equity fund from WhiteOak Capital Mutual Fund with ₹902 Cr under management, launched in 2024. The expense ratio is 2.80% and the SEBI riskometer reading is Very High.
Performance
WhiteOak Capital Pharma and Healthcare Fund NAV and returns
Growth of the fund against its category average over the period you pick.
Over 1Y this fund returned +26.1% against +19.5% for its category.
Performance
Returns
How the fund has done against its category and its benchmark.
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1Y | 34.9% | +14.0 pts | 20.9% | 26.4% |
| 2Y | 22.4% | +5.5 pts | 16.8% | 15.2% |
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1M | 0.9% | +0.8 pts | 0.2% | -0.3% |
| 3M | 7.5% | +1.2 pts | 6.2% | 6.0% |
| 6M | 25.4% | +3.2 pts | 22.1% | 20.9% |
| 1Y | 26.1% | +5.2 pts | 20.9% | 19.5% |
| 2Y | 14.5% | +6.3 pts | 8.2% | 6.5% |
Since launch (16 Jan 2024): 22.0%
Calendar-year returns
Category average0.1%
Show as a table
| Period | Fund | vs category | Category |
|---|---|---|---|
| 2025 | 0.1% | +2.1 pts | -2.0% |
Returns over one year are annualised. Shorter periods are absolute.
Costs & terms
Costs and terms
What the fund charges each year, and the rules around putting money in and taking it out.
Costs
2.75%
Expense ratio as on 25 Sep 2026
Charged yearly and already deducted from the NAV.
- Base expense
- 1.94%
- Brokerage
- 0.13%
- Transaction charges
- 0.01%
- Statutory levies
- 0.67%
- Exit load
- Exit load of 1%, if redeemed within 1 months.
- Lock-in
- None
Terms
- Min SIP
- ₹3,000
- Min lumpsum
- ₹5,000
- Plan
- GROWTH
- Fund type
- OPEN-ENDED
- Benchmark
- BSE Healthcare TRI
- Short-term capital gains
- Returns taxed at 20% if you redeem before 1 year
- Long-term capital gains
- After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5%
Risk
Risk
What the riskometer means for this fund, and how its ratios sit against the category.
Very High
Your principal is treated as being at very high risk — typically small cap, sectoral and thematic equity schemes.
Portfolio
WhiteOak Capital Pharma and Healthcare Fund portfolio
Portfolio as of 31 Aug 2026
Asset allocation
- Equity99.3%
- Debt5.1%
Market cap split
- Large32.7%
- Mid24.3%
- Small43.0%
- P/E
- 53.02
- P/B
- 7.73
Top holdings
| Holding | Sector | Weight | Value | 3M chg | 6M chg | 1Y chg |
|---|---|---|---|---|---|---|
| Divi's Laboratories Ltd. | Healthcare | 8.45% | ₹76.22 Cr | +3.29% | +0.88% | +0.55% |
| Sun Pharmaceutical Industries Ltd. | Healthcare | 7.47% | ₹67.35 Cr | +0.17% | +0.21% | +4.52% |
| Torrent Pharmaceuticals Ltd. | Healthcare | 6.78% | ₹61.21 Cr | — | +0.29% | — |
| Cipla Ltd. | Healthcare | 5.26% | ₹47.42 Cr | +5.15% | — | +9.85% |
| Laurus Labs Ltd. | Healthcare | 5.15% | ₹46.43 Cr | +8.86% | +8.65% | +8.41% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 4.97% | ₹44.81 Cr | +0.59% | +0.70% | +0.86% |
| Aurobindo Pharma Ltd. | Healthcare | 3.83% | ₹34.52 Cr | +3.74% | +3.98% | — |
| Max Healthcare Institute Ltd. | Healthcare | 3.45% | ₹31.14 Cr | +0.66% | +0.93% | +13.98% |
| Sai Life Sciences Ltd. | Healthcare | 3.32% | ₹29.96 Cr | +3.17% | +2.46% | +2.25% |
| Neuland Laboratories Ltd. | Healthcare | 2.88% | ₹25.95 Cr | +2.53% | +1.46% | +2.53% |
| Ipca Laboratories Ltd. | Healthcare | 2.66% | ₹23.98 Cr | +0.92% | +1.96% | — |
| Zydus Lifesciences Ltd. | Healthcare | 2.58% | ₹23.28 Cr | +1.61% | +0.49% | — |
| CORONA Remedies Ltd. | Healthcare | 2.35% | ₹21.20 Cr | +2.32% | +2.31% | — |
| Dr. Lal Pathlabs Ltd. | Healthcare | 2.35% | ₹21.18 Cr | +2.11% | +1.17% | — |
| Thyrocare Technologies Ltd. | Healthcare | 2.31% | ₹20.84 Cr | +2.06% | +0.99% | +2.28% |
| Shaily Engineering Plastics Ltd. | Materials | 2.01% | ₹18.17 Cr | +1.75% | +1.78% | +1.94% |
| Global Health Ltd. | Healthcare | 1.92% | ₹17.33 Cr | — | — | — |
| Krishna Institute of Medical Sciences Ltd | Healthcare | 1.92% | ₹17.32 Cr | +3.44% | +3.95% | +3.81% |
| Narayana Hrudayalaya Ltd. | Healthcare | 1.76% | ₹15.90 Cr | +1.88% | +1.94% | — |
| Ajanta Pharma Ltd. | Healthcare | 1.72% | ₹15.50 Cr | +1.68% | +2.35% | +1.58% |
| Anthem Biosciences Ltd. | Healthcare | 1.68% | ₹15.14 Cr | +0.94% | — | +2.42% |
| Fortis Healthcare Ltd. | Healthcare | 1.65% | ₹14.86 Cr | +3.92% | +0.08% | +6.27% |
| Vijaya Diagnostic Centre Ltd. | Healthcare | 1.59% | ₹14.30 Cr | +1.31% | +1.14% | +2.61% |
| Navin Fluorine International Ltd. | Chemicals | 1.53% | ₹13.77 Cr | +1.17% | +1.60% | +0.80% |
| Acutaas Chemicals Ltd. | Healthcare | 1.44% | ₹12.98 Cr | +2.46% | +2.25% | +1.05% |
| Rainbow Children's Medicare Ltd. | Healthcare | 1.27% | ₹11.44 Cr | +1.59% | — | — |
| Procter & Gamble Health Ltd. | Healthcare | 1.25% | ₹11.29 Cr | +1.41% | — | — |
| Manipal Health Enterprises Ltd. | Healthcare | 1.15% | ₹10.34 Cr | — | — | — |
| Pfizer Ltd. | Healthcare | 1.14% | ₹10.28 Cr | +1.10% | +1.73% | +1.29% |
| Aarti Pharmalabs Ltd. | Services | 1.10% | ₹9.89 Cr | +0.74% | +0.61% | — |
| Onesource Specialty Pharma Ltd. | Healthcare | 1.01% | ₹9.11 Cr | +1.26% | — | +0.45% |
| Kovai Medical Center & Hospital Ltd. | Healthcare | 0.99% | ₹8.93 Cr | +1.07% | +1.32% | +1.78% |
| company:20769 | Healthcare | 0.98% | ₹8.85 Cr | — | — | — |
| Aether Industries Ltd. | Chemicals | 0.97% | ₹8.72 Cr | +1.13% | +1.26% | — |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 0.87% | ₹7.88 Cr | +0.66% | — | +1.55% |
| Senores Pharmaceuticals Ltd. | Healthcare | 0.85% | ₹7.69 Cr | +0.81% | — | — |
| Gland Pharma Ltd. | Healthcare | 0.85% | ₹7.69 Cr | +1.99% | — | +1.90% |
| Poly Medicure Ltd. | Healthcare | 0.76% | ₹6.86 Cr | +0.90% | +0.29% | +0.64% |
| Vimta Labs Ltd. | Healthcare | 0.73% | ₹6.62 Cr | — | — | — |
| Nephrocare Health Services Ltd. | Healthcare | 0.61% | ₹5.50 Cr | +0.60% | — | — |
| Innova Captab Ltd. | Healthcare | 0.61% | ₹5.46 Cr | +1.09% | — | — |
| Supriya Lifescience Ltd. | Healthcare | 0.60% | ₹5.40 Cr | +0.92% | +0.84% | +0.64% |
| Biocon Ltd. | Healthcare | 0.48% | ₹4.34 Cr | — | — | — |
| Sudeep Pharma Ltd. | Healthcare | 0.47% | ₹4.25 Cr | +0.50% | +0.75% | — |
| Orchid Pharma Ltd. | Healthcare | 0.41% | ₹3.66 Cr | +0.27% | +0.26% | +0.49% |
| Tatva Chintan Pharma Chem Ltd. | Chemicals | 0.39% | ₹3.51 Cr | +0.19% | +0.20% | — |
| Reserve Bank of India | Financial | 0.37% | ₹3.37 Cr | +0.60% | +0.93% | +0.28% |
| Zota Health Care Ltd. | Healthcare | 0.34% | ₹3.04 Cr | +0.49% | +0.66% | +0.50% |
| Laxmi Dental Ltd. | Healthcare | 0.24% | ₹2.17 Cr | — | — | +0.24% |
| Cohance Lifesciences Ltd. | Healthcare | 0.21% | ₹1.90 Cr | +0.27% | — | — |
| company:513 | Healthcare | 0.04% | ₹0.39 Cr | — | — | — |
| Others | Others | -1.84% | ₹-16.58 Cr | +7.88% | +5.97% | +14.00% |
Sectors
Instruments
Recent changes
| Holding | From | To | Weight |
|---|---|---|---|
| Divi's Laboratories Ltd. | 3.86% | 8.45% | +4.59% |
| Laurus Labs Ltd. | 4.94% | 1.36% | -3.58% |
| Granules India Ltd. | 1.56% | 0.00% | -1.56% |
| Ipca Laboratories Ltd. | 1.12% | 2.66% | +1.54% |
| Torrent Pharmaceuticals Ltd. | 7.81% | 6.78% | -1.03% |
| company:20769 | 0.00% | 0.98% | +0.98% |
| Global Health Ltd. | 1.18% | 1.92% | +0.74% |
| Shaily Engineering Plastics Ltd. | 1.39% | 2.01% | +0.62% |
| Fortis Healthcare Ltd. | 2.20% | 1.65% | -0.56% |
| Aether Industries Ltd. | 1.47% | 0.97% | -0.51% |
| Innova Captab Ltd. | 1.10% | 0.61% | -0.49% |
| Procter & Gamble Health Ltd. | 1.70% | 1.25% | -0.44% |
| Krishna Institute of Medical Sciences Ltd | 2.34% | 1.92% | -0.42% |
| Zydus Lifesciences Ltd. | 2.94% | 2.58% | -0.36% |
| Rainbow Children's Medicare Ltd. | 1.61% | 1.27% | -0.34% |
| Cipla Ltd. | 2.27% | 2.00% | -0.26% |
| Aarti Pharmalabs Ltd. | 0.85% | 1.10% | +0.25% |
| Anthem Biosciences Ltd. | 1.47% | 1.68% | +0.21% |
| Jupiter Life Line Hospitals Ltd. | 1.07% | 0.87% | -0.20% |
| Dr. Lal Pathlabs Ltd. | 2.53% | 2.35% | -0.18% |
| Manipal Health Enterprises Ltd. | 0.97% | 1.15% | +0.18% |
| Onesource Specialty Pharma Ltd. | 1.18% | 1.01% | -0.17% |
| Poly Medicure Ltd. | 0.91% | 0.76% | -0.15% |
| Sai Life Sciences Ltd. | 3.18% | 3.32% | +0.14% |
| Orchid Pharma Ltd. | 0.27% | 0.41% | +0.14% |
| Thyrocare Technologies Ltd. | 2.20% | 2.31% | +0.11% |
| Zota Health Care Ltd. | 0.45% | 0.34% | -0.11% |
| Pfizer Ltd. | 1.03% | 1.14% | +0.11% |
| Sudeep Pharma Ltd. | 0.37% | 0.47% | +0.10% |
| Ajanta Pharma Ltd. | 1.81% | 1.72% | -0.09% |
| CORONA Remedies Ltd. | 2.44% | 2.35% | -0.09% |
| Tatva Chintan Pharma Chem Ltd. | 0.47% | 0.39% | -0.08% |
| Max Healthcare Institute Ltd. | 0.48% | 0.40% | -0.08% |
| Navin Fluorine International Ltd. | 1.46% | 1.53% | +0.07% |
| Others | 2.51% | 2.58% | +0.07% |
| Biocon Ltd. | 0.54% | 0.48% | -0.06% |
| Gland Pharma Ltd. | 0.91% | 0.85% | -0.06% |
| Nephrocare Health Services Ltd. | 0.67% | 0.61% | -0.06% |
| Narayana Hrudayalaya Ltd. | 1.82% | 1.76% | -0.06% |
| Vijaya Diagnostic Centre Ltd. | 1.54% | 1.59% | +0.05% |
| company:513 | 0.00% | 0.04% | +0.04% |
| Aurobindo Pharma Ltd. | 1.66% | 1.62% | -0.04% |
| Kovai Medical Center & Hospital Ltd. | 0.95% | 0.99% | +0.04% |
| Reserve Bank of India | 0.41% | 0.37% | -0.03% |
| Vimta Labs Ltd. | 0.76% | 0.73% | -0.03% |
| Apollo Hospitals Enterprise Ltd. | 0.26% | 0.23% | -0.02% |
| Laxmi Dental Ltd. | 0.23% | 0.24% | +0.01% |
| Sun Pharmaceutical Industries Ltd. | 0.08% | 0.07% | -0.01% |
| Neuland Laboratories Ltd. | 2.87% | 2.88% | +0.01% |
| Acutaas Chemicals Ltd. | 1.44% | 1.44% | -0.01% |
| Cohance Lifesciences Ltd. | 0.21% | 0.21% | 0.00% |
| Senores Pharmaceuticals Ltd. | 0.85% | 0.85% | 0.00% |
| Supriya Lifescience Ltd. | 0.60% | 0.60% | 0.00% |
Compare
Similar funds
The rest of the category, so this fund’s numbers have something to sit against.
| Fund | AUM | Expense | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| Category average | ₹3,579 Cr | 2.19% | 27.3% | 17.7% | 20.1% |
 ICICI Prudential Healthcare Fund | ₹6,996 Cr | 2.07% | 14.5% | 14.2% | 19.4% |
 SBI Healthcare Opportunities Fund | ₹5,796 Cr | 1.99% | 33.1% | 19.9% | 22.2% |
 Mirae Asset Healthcare Fund | ₹3,555 Cr | 2.03% | 29.9% | 18.4% | 19.7% |
 UTI Healthcare Fund | ₹1,444 Cr | 2.21% | 30.4% | 19.1% | 21.1% |
 LIC MF Healthcare Fund | ₹103 Cr | 2.67% | 28.7% | 16.9% | 17.9% |
About
About this fund
The scheme’s own words, its benchmark and the people running it.
Investment objective
The Scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
Fund managers
- Ashish AgrawalPGDBM in Finance from Institute of Management Technology, Ghaziabad and Bachelor of Commerce from University of LucknowPrior to joining Whiteoak Capital AMC, he was working with Motilal Owal Asset Management Co. Ltd from 2016 till date. Citigroup Global Markets Ltd from 2010 to 2016
- Dheeresh PathakMr. Pathak has done B.E in Electronics Engineering and a PGDBM from MDI GurgaonPrior to joining WhiteOak Capital Mutual Fund, he has worked with Goldman Sachs
- Piyush BaranwalMr.Piyush Baranwal is a B. Tech. in Electronics and communication from Manipal Institute of Technology,Manipal.He completed PGDBM in Finance from S.P.Jain Institute of Management and Reserch and CFA.Prior to joining WhiteOak Capital Mutual Fund he has worked with BOI AXA, Morgan Stanley Investment Management (Jan, 2011-June, 2014) and Principal Pnb AMC as a Dealer- Fixed Income (May, 2008-Jan, 2011).
- Ramesh MantriMr. Mantri is an MBA, CFA and CAPrior to joining WhiteOak Capital Mutual Fund, he has worked with WhiteOak Capital Management, Ashoka Capital Advisers, Smith Management, and CRISIL.
- Trupti AgrawalMs. Agrawal has done B.Com and CA.Prior to joining WhiteOak Capital Mutual Fund, she has worked with L&T Infrastructure Finance Co. Ltd. and Ernst & Young.
Tools
Return calculator
What ₹10,000 a month in this fund would have grown to over each period, based on its past returns.
₹
| Over the past | Total investment | Would’ve become | Growth | Returns |
|---|---|---|---|---|
| 6 months25.36% absolute | ₹60,000 | ₹75,216 | 25.36% | |
| 1 year26.08% annualised | ₹1,20,000 | ₹1,38,379 | 15.32% |
Returns for 1 year and longer are annualised (CAGR); 6-month figures are absolute. Past returns are not a forecast.
How this is calculated
Each monthly instalment grows at the fund’s annualised return ÷ 12 per month until the end of the period, the same formula as our SIP calculator.
The amount compounds once a year at the fund’s CAGR for that period, the same formula as our lumpsum calculator.
Questions
Frequently asked questions
The things people ask about this scheme.
What is the NAV of WhiteOak Capital Pharma and Healthcare Fund?
The NAV of WhiteOak Capital Pharma and Healthcare Fund is ₹17.02 as on 25 Sep 2026.
What is the expense ratio of WhiteOak Capital Pharma and Healthcare Fund?
The expense ratio of WhiteOak Capital Pharma and Healthcare Fund is 2.80% per year.
What is the minimum SIP amount for WhiteOak Capital Pharma and Healthcare Fund?
You can start a SIP in WhiteOak Capital Pharma and Healthcare Fund with ₹3,000 a month.
Is there a lock-in or exit load on WhiteOak Capital Pharma and Healthcare Fund?
Lock-in: None. Exit load: Exit load of 1%, if redeemed within 1 months..
How risky is WhiteOak Capital Pharma and Healthcare Fund?
WhiteOak Capital Pharma and Healthcare Fund is rated Very High on the SEBI riskometer and belongs to the Sectoral-Pharma category.
Which fund house manages WhiteOak Capital Pharma and Healthcare Fund?
WhiteOak Capital Pharma and Healthcare Fund is managed by WhiteOak Capital Mutual Fund, which runs 22 schemes with ₹37,389 Cr under management.